Cargando…
Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series
OBJECTIVES: To present our experience with ammonium tetrathiomolybdate (ATTM) in the decoppering phase treatment of Wilson's disease (WD) with neurological symptoms. METHODS: An uncontrolled longitudinal study was carried out to describe a case series of five patients diagnosed of WD with neuro...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218247/ https://www.ncbi.nlm.nih.gov/pubmed/32202078 http://dx.doi.org/10.1002/brb3.1596 |